These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37119578)

  • 41. Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study.
    Moavero R; Cusmai R; Specchio N; Fusco L; Capuano A; Curatolo P; Vigevano F
    Epilepsy Res; 2012 Nov; 102(1-2):94-9. PubMed ID: 22677424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rufinamide add-on therapy for refractory epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011772. PubMed ID: 29691835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carisbamate add-on therapy for drug-resistant focal epilepsy.
    Lu C; Zheng J; Cao Y; Bresnahan R; Martin-McGill KJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012121. PubMed ID: 34870321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of "benign" partial epilepsies of childhood, including atypical forms.
    Gross-Selbeck G
    Neuropediatrics; 1995 Feb; 26(1):45-50. PubMed ID: 7791951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood.
    von Stülpnagel C; Kluger G; Leiz S; Holthausen H
    Epilepsy Behav; 2010 Feb; 17(2):193-8. PubMed ID: 20045383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lacosamide add-on therapy for partial epilepsy.
    Weston J; Shukralla A; McKay AJ; Marson AG
    Cochrane Database Syst Rev; 2015 Jun; (6):CD008841. PubMed ID: 26077821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M; Al-Bachari S; Weston J; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001415. PubMed ID: 30357813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retrospective comparison of efficacy of levetiracetam and lacosamide add-on treatments in patients with partial onset seizure.
    Acar T; Aras YG
    Ideggyogy Sz; 2018 May; 71(5-06):197-204. PubMed ID: 29889462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center.
    Green SF; Hare N; Kassam M; Rugg-Gunn F; Koepp MJ; Sander JW; Rajakulendran S
    Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
    Chaisewikul R; Privitera MD; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of antiseizure medication with a very long half-life on long term video-EEG monitoring in focal epilepsy.
    Hampel KG; Morata-Martínez C; Garcés-Sánchez M; Villanueva V
    Seizure; 2024 Feb; 115():100-108. PubMed ID: 38158320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment registry in focal epilepsy (TRIP): multicenter observational study in Lebanon.
    Beydoun A; Sawaya MT; Alam E; Hmaimess G; Ezzeddine K; Younes F
    Seizure; 2015 Apr; 27():54-9. PubMed ID: 25891928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CLB add-on treatment in patients with epileptic encephalopathy: a single center experience with long-term follow-up.
    Türkdoğan D; Öztürk G
    Acta Neurol Belg; 2022 Feb; 122(1):51-57. PubMed ID: 33782854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etiology-specific response to antiseizure medication in focal epilepsy.
    Doerrfuss JI; Kowski AB; Holtkamp M
    Epilepsia; 2021 Sep; 62(9):2133-2141. PubMed ID: 34328218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increasing the dosage of pregabalin in patients with focal epilepsy decreases the frequency of seizures and ameliorates symptoms of anxiety, depression and insomnia.
    Murawiec S; Chudek J; Nieves W; Almgren-Rachtan A; Jedrzejczak J
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13015-13024. PubMed ID: 33378053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.